GoldArc Resources (ASX:GA8): Building a bigger Leonora gold hub as drilling accelerates
Transcription of The Stock Network Interview with GoldArc Resources (ASX:GA8), Managing Director Paul Stephen Lel Smits: Gold Arc Resources is rapidly consolidating its position across Western Australia’s prolific Leonora and Kukaini districts, with drilling extending gold anomalies and high-grade results continuing to emerge across its portfolio. Ahead of presenting at Sydney Mining Club, I’m joined […]
EBR Systems (ASX:EBR) advances life-saving cardiac resynchronisation into the wireless age
WiSE CRT is the first leadless CRT system to win FDA pre-market approval. 117 US commercial procedures completed by the end of Q2 2026. Master purchasing agreements signed with three of the top 10 US purchasing groups. CMS has opened a national coverage analysis under the TCET pathway. EBR Systems holds the world’s only […]
Acrux (ASX:ACR) pushes Female Testosterone MDTS toward Phase III on stated FDA feedback
Acrux says FDA feedback confirms its Phase I and II data give it a clear pathway to Phase III and US registration for Female Testosterone. Combined US and EU addressable market for HSDD, is estimated at US$21.3 billion a year. FY26 customer receipts increased 860% to $5 million. The FDA is holding a public meeting […]
Argo Investments (ASX:ARG): Finding income and the human edge in the age of AI
Transcription of The Stock Network Interview with Argo Investments (ASX:ARG), Managing Director Jason Beddow Lel Smits: As artificial intelligence reshapes investment markets, the value of human judgment experience and active management remains critical. Argo Investments, one of Australia’s oldest listed investment companies, is navigating this challenging environment while maintaining its focus on delivering sustainable income […]
Myopharm: Advancing TriGlytza® as a new treatment for Type 2 diabetes
Transcription of The Stock Network Interview with Myopharm, CEO and Executive Chair Karinza Phoenix Lel Smits: Myopharm is developing treatments for metabolic and inflammatory diseases led by its type 2 diabetes drug candidate TriGlytza. A recent preclinical study achieved its key HbA1c endpoint and reported stronger results than metformin over one month of treatment. I’m […]
Change Financial (ASX:CCA): Record results mark maiden full year profit
Transcription of The Stock Network Interview with Change Financial (ASX:CCA), CEO Tony Sheehan Lel Smits: Change Financial has delivered a landmark FY26 result, achieving its maiden four-year profit and beating upgraded revenue and EBITDA guidance. Revenue grew 21% while underlying EBITDA surged 17 times and the company’s Vertex and Pass platform continues to scale rapidly […]
Imagion Biosystems (ASX:IBX): How MagSense® is moving towards Phase 2 clinical trials
Transcription of The Stock Network Interview with Imagion Biosystems (ASX:IBX), Chair Bob Proulx Lel Smits: Imagium Biosystems is advancing a new approach to cancer detection with MagSense, its non-radioactive bio-safe molecular MRI imaging agent designed to help clinicians detect cancer earlier and with greater precision.Imagion Imagium Biosystems is initially focused on HER2 plus breast cancer […]
Pengana Global Private Credit Trust (ASX:PCX): Private credit is booming, how you access it matters
Transcription of The Stock Network Interview with Pengana Global Private Credit Trust (ASX:PCX), CEO Nehemiah Richardson Lel Smits: Global private debt assets under management reached two trillion US dollars by mid last year with the broader private credit ecosystem estimated at around four trillion US dollars. Pangana Global Private Credit Trust gives Australian investors access […]
Maritana Minerals (ASX:MRT): Gold reserves surge 148% as WA growth accelerates
Transcription of The Stock Network Interview with Maritana Minerals (ASX:MRT), Managing Director and CEO Grant Haywood Lel Smits: Maritana Minerals has delivered a 148% increase in gold ore reserves alongside a 6.3% increase in gold mineral resources, strengthening its position as an emerging Western Australian gold producer. Ahead of presenting at the Sydney Mining Club, […]
Michael Hill International (ASX/NZX:MHJ): Turnaround delivers record results and renewed growth
Transcription of The Stock Network Interview with Michael Hill International (ASX/NZX:MHJ), CEO Jonathan Waecker Lel Smits: Michael Hill International has just reported record FY26 results, marking a significant step forward in its turnaround strategy and returning the business to growth across Australia, New Zealand and Canada. Under new leadership, the company has simplified the business, […]